Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe.

Courtney Davis Anita Katharina Wagner Maximilian Salcher-Konrad Henry Scowcroft Barbara J Mintzes Adrian M J Pokorny Jianhui Lew Huseyin Naci

Published in: BMJ (Clinical research ed.) (2023)

The findings of this study highlight the need to improve the communication of the benefits and related uncertainties of anticancer drugs in regulated information sources in Europe to support evidence informed decision making by patients and their clinicians.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
palliative care
decision making
transcription factor
health information
drinking water
electronic health record